These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8398010)

  • 1. Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis.
    Sowers JR; Standley PR; Ram JL; Jacober S; Simpson L; Rose K
    Am J Hypertens; 1993 Jul; 6(7 Pt 2):260S-270S. PubMed ID: 8398010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular insulin abnormalities, hypertension, and accelerated atherosclerosis.
    Standley PR; Bakir MH; Sowers JR
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):39-46. PubMed ID: 8503434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data].
    Valensi P
    Presse Med; 1992 Sep; 21(28):1307-11. PubMed ID: 1438099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hypertension and subtle and overt abnormalities of carbohydrate metabolism.
    Sowers JR
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S39-47. PubMed ID: 16989076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin resistance and atherosclerosis].
    Nunes JS; Correia LG; Corrêa JN
    Acta Med Port; 2000; 13(4):203-10. PubMed ID: 11155488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
    DeFronzo RA; Ferrannini E
    Diabetes Care; 1991 Mar; 14(3):173-94. PubMed ID: 2044434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance. An often unrecognized problem accompanying chronic medical disorders.
    Bell DS
    Postgrad Med; 1993 May; 93(7):99-103, 106-7. PubMed ID: 8098525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin therapy in diabetic patient with hypertension].
    Hamaguchi T; Namba M
    Nihon Rinsho; 2003 Jul; 61(7):1238-44. PubMed ID: 12877091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinemia and atherosclerosis.
    Standl E
    Clin Invest Med; 1995 Aug; 18(4):261-6. PubMed ID: 8549011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to prevent the incidence of hypertension in type 2 diabetes patients].
    Murakami H; Shimamoto K
    Nihon Rinsho; 2003 Jul; 61(7):1154-60. PubMed ID: 12877077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Theoretical aspects of the relationship between diabetic macroangiopathy and hyperinsulinism].
    Leutenegger M
    Presse Med; 1992 Sep; 21(28):1324-9. PubMed ID: 1438101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperinsulinemia and cardiovascular risk].
    Brunelli C; Spallarossa P; Cordera R; Caponnetto S
    Cardiologia; 1994 Dec; 39(12 Suppl 1):163-8. PubMed ID: 7634261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucose intolerance: postprandial hyper glucose, risk factor for diabetic macroangiopathy].
    Igarashi Y; Kawamori R
    Nihon Rinsho; 2006 Nov; 64(11):1998-2004. PubMed ID: 17087289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis, the major complication of diabetes.
    Steiner G
    Adv Exp Med Biol; 1985; 189():277-97. PubMed ID: 4036715
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of diabetic macroangiopathy].
    Nishio Y
    Nihon Rinsho; 2006 Nov; 64(11):1991-7. PubMed ID: 17087288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.